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ABSTRACT 
Heart rate variability (HRV) is a physiologic phenomenon that occurs due to changing 
autonomic tone resulting in variable RR intervals. A reduction in HRV is used as an index of 
pain in neonatal human patients. Objective measures of pain would be valuable in the evaluation 
of canine patients and assessment of response to pain management strategies. We hypothesized 
that dogs with diseases associated with discomfort (osteoarthritis and bone neoplasia) would 
have reduced HRV compared with normal, healthy dogs. The aim of the study was to calculate 
the sample size necessary to investigate this hypothesis. 
Seventeen dogs from the Ryan Veterinary Hospital of the University of Pennsylvania patient 
population or owned by Ryan Veterinary Hospital of the University of Pennsylvania staff were 
enrolled in this single-blind, prospective pilot study. A 30 min electrocardiogram (EKG) was 
obtained from each dog using an ambulatory electrocardiographic monitor. All EKGs were 
obtained between 10 a.m. and 2 p.m. EKGs were analyzed and time-domain HRV indices 
computed.  
Sample size calculations suggest that 207 dogs would be necessary to ascertain if HRV is 
reduced in dogs experiencing discomfort or pain (50 in the arthritis group, 79 in the bone cancer 
group, and 78 in the control group).  
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<1>Introduction 
Heart rate variability (HRV) is a physiologic phenomenon that occurs due to changing 
autonomic tone. It refers to the oscillation in the interval between consecutive R waves. HRV 
can be quantified by either time- or frequency-domain analysis. Time-domain analysis relies on 
mathematical quantification of the variability of RR intervals, whereas frequency-domain 
analysis is a more complex evaluation of the periodicity of RR intervals.1  
Change in the HRV pattern is an early and sensitive indicator of compromised human health.2 
High HRV is a sign of a healthy individual whereas lower variability is an indicator of abnormal 
autonomic adaptability and the presence of physiologic abnormality.2 Reduced HRV is a strong, 
independent predictor of mortality and arrhythmic complications after acute myocardial 
infarction, and reduced HRV has been consistently observed in human patients with cardiac 
failure.3 It also predicts the clinical expression of autonomic neuropathy in diabetic patients.3  
In humans, HRV is also a useful marker for many noncardiac diseases.2 Reduced HRV has been 
used as a marker for pain in neonatal human patients and has been suggested as a method for 
measuring stress responses and welfare states in farm animal species.4,5 The assessment of pain 
in canine patients is challenging, and few objective measures are available; such markers would 
have obvious clinical utility. 
In dogs, the influence of a variety of cardiac diseases on HRV has been investigated.6–8 
However, HRV has not been evaluated in the presence of noncardiac disease, nor has its 
potential use as an objective marker of pain been investigated. The purpose of this pilot study 
was to determine the appropriate sample size necessary to ascertain if HRV is reduced in dogs 
experiencing discomfort or pain. Our hypothesis for this larger study is that time-domain indices 
of HRV would differentiate normal dogs from dogs experiencing lameness due to arthritis or 
bone cancer and that the magnitude of the decrease in HRV would be correlated with pain 
severity.  
 
<1>Materials and Methods  
This study was approved by the University of Pennsylvania Institutional Animal Care and Use 
Committee. Dogs with osteoarthritis (n = 6) or neoplasia (n = 4) causing lameness were 
evaluated at the Ryan Veterinary Hospital of the University of Pennsylvania by the Veterinary 
Clinical Investigations Center to be considered for enrollment in a pain management clinical 
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trial. At the time of this initial examination, no dogs were receiving therapy for pain 
management. As part of that study, a client questionnaire was completed regarding the perceived 
level of pain for each dog. Definitive diagnosis of the form of bone cancer was not necessary for 
enrollment in this study and was not available for most of the dogs. Clients who gave informed 
consent for their dog to be included in this pilot study evaluating HRV were asked to wait in a 
quiet room with their pet for the duration of the study. The dog was fitted with an ambulatory 
electrocardiographic monitora: Sufficient fur was clipped over the areas of the left and right 
palpable apex heart beats and the skin wiped with acetone to remove surface grease. Once dry, 
adhesive electrocardiographic (EKG) electrodes were applied to the skin and the Holter monitor 
attached to the electrodes. A snugly fitting vestb was placed over the dog’s thorax to prevent 
dislodgement; no bandage material was used. A period of acclimation was allowed. Once the 
dogs appeared relaxed, a 30 min EKG was obtained, during which time the dogs remained at rest 
in a small examination room with their owners. All EKGs were obtained between 10 a.m. and 2 
p.m. to reduce the influence of circadian rhythms on the recordings. EKGs were uploaded into 
the Spacelab system using Impresario software. EKGs were manually analyzed beat by beat to 
ensure that beats were labeled correctly by the computer software. Time-domain HRV indices 
were then computed by the software, including successive NNs (normal RR intervals) differing 
by more than 50 ms, SDNN (ms) or the standard deviation of the NN interval, RMSDD (ms) or 
the square root of the mean squared differences of successive NN intervals, SDSD (ms) or the 
standard deviation of successive NN differences, TINN (ms) or the triangular interpolation of 
NN intervals, HRV index (ms), mean RR (ms), and mean heart rate (beats per min).  
A group of seven normal dogs underwent the same EKG evaluation following owner consent. 
These animals were owned by hospital staff or students and were normal on physical 
examination, and no ectopy was present in their 30 min EKGs from which HRV was derived.  
 
<2>Statistics 
Statistical analysis was performed using commercially available software packagesc,d. Data was 
assessed graphically for normality of distribution. For categorical data, groups were compared 
                                                 
a Spacelabs Healthcare, Issaquah, Washington 
b Surgi-Sox by DogLeggs, Reston, Virginia 
c SPSS 22; IBM, Armonk, New York 
d PSS; Vanderbilt University, Nashville, Tennessee 
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using Fisher exact test. Overall between-group comparisons were performed using Student t tests 
or Kruskall-Wallis tests, as appropriate.  
 
<1>Results 
Results are summarized in Table 1. There was no significant difference among groups for age (P 
= .148), sex (P = .768), or body weight (P = .663). There was no significant difference among 
groups for any of the time-domain HRV indices. No significant difference was detected in 
owner-estimated pain score between the osteoarthritis (mean = 15.8 ± 6.71) and neoplasia (mean 
= 19.3 ± 9.64) groups (P = .714). A sample size calculation suggested that a total of 207 dogs 
would be necessary to demonstrate a difference in time-domain HRV indices among groups (50 
in the arthritis group, 79 in the bone cancer group, and 78 in the control group). 
 
<1>Discussion 
HRV analysis has been shown in several studies to measure autonomic nervous system activity, 
which is strongly influenced by pain or stress.2,3 Results from various human studies evaluating 
subjects ranging from pain in neonates to patients with posttraumatic stress disorder have 
suggested that decreased HRV may be a useful indicator of pain.4,9 However, to our knowledge, 
this is the first study to evaluate HRV as an indicator of pain in clinical canine patients. 
Our results suggest that changes in time-domain indices of HRV are relatively small in situations 
of stress or discomfort in dogs, and therefore relatively large numbers of dogs would be 
necessary to determine whether significant differences exist. Factors other than pain may have 
contributed to the findings of the present study. For example, all of the measurements were 
performed in the hospital, and it is possible that the stress of being in the hospital masked any 
effect of pain or discomfort on HRV. Evaluation of HRV in dogs within their home 
environments would be necessary to further investigate this possibility. It is also possible that 
discomfort is not associated with measureable changes in HRV indices in dogs, such that an 
appropriately powered study would not demonstrate significant differences among groups. 
Further study using the calculated sample size of 207 dogs is therefore warranted to further 
investigate the possible utility of time-domain indices of HRV as markers of stress or discomfort 
in dogs. 
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In the present study, 30 min recordings were obtained between 10 a.m. and 2 p.m. This 4 hr time 
window was selected to allow the owners of the dogs some flexibility in scheduling the time of 
their participation, while reducing the influence of circadian rhythms on the results of the study. 
In the morning, sympathetic tone is dominant, whereas in the afternoon, parasympathetic tone is 
dominant.2 Previous studies have not identified an optimal data acquisition period, with 
investigators reporting periods of between 5 min and 24 hr. However, it is believed that reliable 
data is best obtained under controlled conditions, and so a 30 min acquisition period during rest 
with the owners present was chosen to minimize variability.2  
 
<1>Conclusion   
In conclusion, the results of this pilot study suggest that a total of 207 dogs would be necessary 
to ascertain if HRV is reduced in dogs experiencing discomfort or pain (50 in the arthritis group, 
79 in the bone cancer group, and 78 in the control group). 
 
REFERENCES 
1. Pereira YM, Woolley R, Culshaw G, et al. The vasovagal tonus index as a prognostic indicator 
in dogs with dilated cardiomyopathy. J Small Anim Pract 2008;49(11):587–92. 
2. Pumprla J, Howorka K, Groves D, et al. Functional assessment of heart rate variability: 
physiological basis and practical applications. Int J Cardiol 2002;84(1):1–14. 
3. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. 
Task Force of the European Society of Cardiology and the North American Society of Pacing 
and Electrophysiology. Eur Heart J 1996;17:354–81. 
4. Faye PM, De Jonckheere J, Logier R, et al. Newborn infant pain assessment using heart rate 
variability analysis. Clin J Pain 2010;26(9):777–82. 
5. von Borell E, Langbein J, Despres G, et al. Heart rate variability as a measure of autonomic 
regulation of cardiac activity for assessing stress and welfare in farm animals -- a review. Physiol 
Behav 2007;92(3):293–316. 
6. Rasmussen CE, Falk T, Zois NE, et al. Heart rate, heart rate variability, and arrhythmias in 
dogs with myxomatous mitral valve disease. J Vet Intern Med 2012;26(1):76–84. 
7. Calvert CA, Wall TM. Correlations among time and frequency measures of heart rate 
variability recorded by use of a Holter monitor in overtly healthy Doberman pinschers with and 
 8 
without echocardiographic evidence of dilated cardiomyopathy. Am J Vet Res 
2001;62(11):1787–92. 
8. Spier AW, Meurs KM. Assessment of heart rate variability in Boxers with arrhythmogenic 
right ventricular cardiomyopathy. J Am Vet Med Assoc 2004;224(4):534–7. 
9. Hallman DM, Lyskov E. Autonomic regulation, physical activity and perceived stress in 
subjects with musculoskeletal pain: 24-hour ambulatory monitoring. Int J Psychophysiol 
2012;86(3):276–82. 
  
 9 
TABLE 1 
Population Data and Indices of Time-Domain Heart Rate Variability for Arthritis, 
Neoplasia, and Control Groups  
Characteristics, n = 
17 
Arthritis, n = 6 Neoplasia, n = 4 Control, n = 7 P 
Age, yr (range) 8.5 
(8.0–10.3) 
9.5 
(6.0–13.0) 
8.0 
(7.0–8.0) 
.148 
Weight, kg (range) 32.5 
(24.8–43.8) 
54.5 
(26.0–71.8) 
31.0 
(28.0–33.7) 
.663 
Sex, male/female 2/4 2/2 2/5 .768 
Successive NNs, 
number differing  
by >50 ms (range) 
753.5 
(538.0–853.5) 
1510.0 
(453.5–1740.0) 
1041.0 
(326.0–1571.0) 
.372 
SDNN, ms (range) 91.2 
(83.3–119.4) 
193.1 
(70.9–344.2) 
143.8 
(84.4–250.5) 
.272 
RMSDD, ms (range) 64.5 
(58.7–97.2) 
277.1 
(58.2–414.7) 
166.8 
(52.9–198.9) 
.240 
SDSD, ms (range) 52.3 
(44.6–80.4) 
161.4 
(42.2–268.0) 
140.6 
(43.9–171.4) 
.254 
HRV index, ms 
(range) 
12.5 
(10.4–13.6) 
15.1 
(7.9–18.8) 
12.2 
(8.0–15.7) 
.876 
TINN, ms (range) 332.1 
(140.7–375.0) 
242.2 
(175.8–384.8) 
296.9 
(156.3–437.5) 
.945 
Mean RR, ms (range) 527.9 
(467.9–629.0) 
776.4 
(530.0–951.5) 
643.9 
(512.1–833.1) 
.178 
Mean HR, bpm 
(range) 
117.5 
(99.0–135.5) 
85.1 
(70.9–116.7) 
98.2 
(78.2–120.2) 
.179 
The median and interquartile ranges are shown for continuous variables. P is the probability that 
no difference exists between groups. 
HR, heart rate; HRV, heart rate variability; NN, normal RR intervals; SDNN, standard deviation 
of the NN interval; RMSDD, square root of the mean squared differences of successive NN 
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intervals; SDSD, standard deviation of successive NN differences; TINN, triangular interpolation 
of NN intervals. 
 
